Arachidonic Acid Treatment Against Schistosomiasis Infection in Children

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized Controlled Trial:

The investigational materials used in this trial were administered to subjects each day by trained clinicians.

Primary Objectives:

• assess the effect of dietary supplementation with arachidonic acid on the cure rates for Schistosomiasis mansoni with and without concomitant treatment with praziquantel.

• assess the safety of dietary supplementation using arachidonic acid in children with clinically confirmed schistosomiasis mansoni infection.

Secondary objective:

• to measure changes in total phospholipids in plasma.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: DSM Nutritional Products, Inc.
• Collaborators: Cairo University; High Institute of Public Health, Egypt; National Liver Institute, Egypt
• Treatments: Praziquantel

Criteria

Inclusion Criteria:

• consent from parent or legal guardian

• clinically confirmed schistosomiasis

Exclusion Criteria:

• not infected with schistosomiasis

• less than 6 or greater than 15 years of age